UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 17, 2022
OraSure Technologies, Inc.
(Exact Name of Registrant as Specified in Charter)
| | | | |
Delaware | | 001-16537 | | 36-4370966 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| |
220 East First Street | |
Bethlehem, Pennsylvania | 18015-1360 |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: 610-882-1820
Securities registered pursuant to Section 12(b) of the Act:
| | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock, $0.000001 par value per share | | OSUR | | The NASDAQ Stock Market LLC |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by a check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
1
Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 17, 2022, at the 2022 Annual Meeting of Stockholders (the “Annual Meeting”) of OraSure Technologies, Inc. (the “Company”), the stockholders of the Company approved an amendment and restatement of the OraSure Technologies, Inc. 2000 Stock Award Plan (the “Stock Award Plan”) to increase the number of shares of common stock authorized for grant thereunder by 1,500,000 shares.
A detailed summary of the material features of the Stock Award Plan is set forth in the Company’s definitive proxy statement for the Annual Meeting filed with the U.S. Securities and Exchange Commission on April 7, 2022 (the “Proxy Statement”) under the caption “Proposals Requiring Your Vote—Proposal 4 - Amendment and Restatement of Stock Award Plan,” which description is incorporated herein by reference.
The descriptions of the Stock Award Plan contained herein and in the Proxy Statement do not purport to be complete and are qualified in their entirety by reference to the full text of the Stock Award Plan, which is attached hereto as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 5.07 - Submission of Matters to a Vote of Security Holders.
On May 17, 2022, the Company held its Annual Meeting virtually. As of March 23, 2022, the record date for the Annual Meeting, there were 73,916,495 outstanding shares of the Company’s common stock. The following is a summary of the items considered by stockholders and the corresponding voting results at the Annual Meeting:
Item 1 - Election of Two Class I Directors for Terms Ending in 2025.
| | | | |
Nominee | Votes For | Votes Against | Abstentions | Broker Non-Votes |
Eamonn P. Hobbs | 55,710,755 | 2,509,206 | 116,641 | 6,035,858 |
| | | | |
David J. Shulkin, M.D. | 56,141,819 | 2,065,594 | 129,189 | 6,035,858 |
Item 2 - Proposal to Ratify the Appointment of KPMG LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal Year 2022.
| | |
Votes For | Votes Against | Abstentions |
60,240,260 | 4,107,860 | 24,340 |
Item 3 - Proposal to Approve an Advisory (Non-Binding) Resolution on the Company’s Executive Compensation.
| | | |
Votes For | Votes Against | Abstentions | Broker Non-Votes |
56,687,157 | 1,535,739 | 113,706 | 6,035,858 |
Item 4 - Proposal to Approve the Company’s Amended and Restated Stock Award Plan to Increase the Shares Authorized for Issuance Thereunder.
| | | |
Votes For | Votes Against | Abstentions | Broker Non-Votes |
53,803,395 | 4,412,702 | 120,505 | 6,035,858 |
2
Item 9.01 – Financial Statements and Exhibits
(d) Exhibits
The following exhibits are being filed herewith:
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| ORASURE TECHNOLOGIES, INC. |
| |
Date: May 18, 2022 | By: | /s/ Scott Gleason |
| | Scott Gleason |
| | Interim Chief Financial Officer and Senior Vice President, Investor Relations and Corporate Communications |
4
